Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus.
about
Role of CD1d-restricted NKT cells in microbial immunityRole of NK, NKT cells and macrophages in liver transplantationEBV promotes human CD8 NKT cell developmentEndonuclease G is required for early embryogenesis and normal apoptosis in miceToll-like receptor 3 ligand dampens liver inflammation by stimulating Valpha 14 invariant natural killer T cells to negatively regulate gammadeltaT cells.V(alpha)14iNKT cells promote liver pathology during adenovirus infection by inducing CCL5 production: implications for gene therapy.Isolation of murine hepatic lymphocytes using mechanical dissection for phenotypic and functional analysis of NK1.1+ cells.NK cell-like behavior of Valpha14i NK T cells during MCMV infection.An MHC class Ib-restricted CD8+ T cell response to lymphocytic choriomeningitis virus.Development of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7The ROS scavenger, NAC, regulates hepatic Vα14iNKT cells signaling during Fas mAb-dependent fulminant liver failure.A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection.The Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their ProductsNKT cells and viral immunity.Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damagesThe response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion.GIT2 deficiency attenuates concanavalin A-induced hepatitis in miceCD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection.c-Jun NH2-terminal kinase 2 inhibits gamma interferon production during Anaplasma phagocytophilum infection.Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma.The in vivo response of invariant natural killer T cells to glycolipid antigens.Role of NKT cells in the digestive system. I. Invariant NKT cells and liver diseases: is there strength in numbers?TCR-dependent and -independent activation underlie liver-specific regulation of NKT cells.Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases.Intracellular bacterial infection and invariant NKT cells.Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride.Natural killer T cells contribute to the control of acute retroviral infection.NKT cells: friend or foe during viral infections?The invariant NKT cell subset in anti-viral defenses: a dark horse in anti-influenza immunity?Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses.Circulating natural killer and gammadelta T cells decrease soon after infection of rhesus macaques with lymphocytic choriomeningitis virus.CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo.Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus.Key role for respiratory CD103(+) dendritic cells, IFN-γ, and IL-17 in protection against Streptococcus pneumoniae infection in response to α-galactosylceramide.Improvement of HBsAg gene-modified dendritic cell-based vaccine efficacy by optimizing immunization method or the application of β-glucosylceramide.Innate immune response to encephalomyocarditis virus infection mediated by CD1d.Reduction in CD1d expression on dendritic cells and macrophages by an acute virus infection.Critical Role for Very-Long Chain Sphingolipids in Invariant Natural Killer T Cell Development and Homeostasis.Telomere length in human natural killer cell subsets.Dissociated expression of natural killer 1.1 and T-cell receptor by invariant natural killer T cells after interleukin-12 receptor and T-cell receptor signalling
P2860
Q24294851-36D564AA-C8B8-4396-B13E-B47F5245D140Q26741191-46AA8AE3-9050-4BC5-A96E-2CB78F9C6E00Q27314724-24902368-7056-4888-BE66-00C2B9577BE9Q28585337-ED4D57B0-9079-4B17-A956-872B6C31C88FQ30432794-3E963472-06B4-4A92-9CB6-7CEB510C84C7Q30433085-00089095-8001-4063-B484-251438FE2EBBQ33204301-5E6EEB4A-C48C-431D-8A65-331FC1075EE5Q33352690-D88C80CA-B63F-43BB-8B98-2881D22741D3Q33702486-E4F8A85D-D208-49CC-80CF-31117381DD3FQ33782527-1E5EB48C-F69A-4CE5-B326-82C4E7CC1B30Q34305284-67FA547D-6628-4B60-A23A-CF6503AAEB26Q35235639-4368363D-4C8A-4989-9253-07FA7C0A528CQ35600087-ABCEFCF8-6807-45F6-B5D3-B3FA8F2CB7D0Q35798179-3D28C06D-FF06-469B-821E-B08F88DA1E48Q35841871-E3E23193-1F2E-4CED-B134-EEC92A33FB21Q35978664-E268374C-01DD-4CA0-BB96-F7FF1DB90A4EQ36017085-2CA64268-3815-444C-B4C7-3B21AAC46529Q36370230-E2B43793-3CDA-4FD6-A48B-779807524D1FQ36422142-D573EAC6-4B26-4095-B835-039A4CFE7EA4Q36713547-2843BCE7-D030-40FE-82F6-7CDA4EB0C9FCQ36799681-D9AA284E-07D7-4B42-A88F-C4EE8AF821B6Q36879807-CD41112C-4D08-44B6-86BA-980DF9BE982EQ37051132-9BA7BC16-0698-477D-96F3-33291F71656AQ37326768-338FE09F-6E08-4E51-A9D3-D5BF5C628E4AQ37405955-CD604A69-46A4-4DE6-A561-2CE51648CDDBQ37411006-7FE94163-5CA3-4E1B-9A03-5067D42986E2Q37607753-E405DD6E-7D6B-44AD-A52D-8145238EC96DQ37615203-4CAF1316-7B84-4366-8E68-C55F09C46BA1Q37762343-95E76848-EAF8-47F2-BD67-649281FA87CEQ38764629-404FD0C2-4722-48F3-A3BE-FA294B09653FQ40381119-E4EAA839-2A66-48DF-A421-43D278478822Q41494923-4F87357A-D0F2-44C2-9BE7-BD0242C50889Q42129273-E7D1F4FC-7281-43C0-B441-55911B3F4E58Q42717336-89CF6E02-536E-41A1-AC3A-6DFD95561E67Q44408019-31E308F9-8EC0-4AAE-A7DC-7D05628F53B3Q44665307-F76CE3FC-36CF-4237-9660-05E8A6FE4268Q45550503-2B0667A9-FF2A-457A-939F-36F344898C0BQ47132347-492B92AB-DD9E-457E-8C7C-4F0C215DAC05Q53570823-E90E2BA5-CC3D-4DA2-AC9B-8DCAABAA7B14Q57598581-C960440F-F757-46D1-8AB9-C727ABE3D36A
P2860
Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Selective loss of natural kill ...... ocytic choriomeningitis virus.
@ast
Selective loss of natural kill ...... ocytic choriomeningitis virus.
@en
type
label
Selective loss of natural kill ...... ocytic choriomeningitis virus.
@ast
Selective loss of natural kill ...... ocytic choriomeningitis virus.
@en
prefLabel
Selective loss of natural kill ...... ocytic choriomeningitis virus.
@ast
Selective loss of natural kill ...... ocytic choriomeningitis virus.
@en
P2093
P2860
P1433
P1476
Selective loss of natural kill ...... hocytic choriomeningitis virus
@en
P2093
P2860
P304
10746-10754
P356
10.1128/JVI.75.22.10746-10754.2001
P577
2001-11-01T00:00:00Z